Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial.

Cosman, Felicia; Miller, Paul D; Williams, Gregory C; Hattersley, Gary; Hu, Ming-Yi; Valter, Ivo; Fitzpatrick, Lorraine A; Riis, Bente Juel; Christiansen, Claus; Bilezikian, John P; Black, Dennis.
Mayo Clin Proc; 92(2): 200-210, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28160873